Anti-ST7 monoclonal antibody

Pre-made anti-ST7 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ST7/ST7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1833-Ab-1/ GM-Tg-hg-IP1833-Ab-2Anti-Human ST7 monoclonal antibodyHuman
GM-Tg-rg-IP1833-Ab-1/ GM-Tg-rg-IP1833-Ab-2Anti-Rat ST7 monoclonal antibodyRat
GM-Tg-mg-IP1833-Ab-1/ GM-Tg-mg-IP1833-Ab-2Anti-Mouse ST7 monoclonal antibodyMouse
GM-Tg-cynog-IP1833-Ab-1/ GM-Tg-cynog-IP1833-Ab-2Anti-Cynomolgus/ Rhesus macaque ST7 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1833-Ab-1/ GM-Tg-felg-IP1833-Ab-2Anti-Feline ST7 monoclonal antibodyFeline
GM-Tg-cang-IP1833-Ab-1/ GM-Tg-cang-IP1833-Ab-2Anti-Canine ST7 monoclonal antibodyCanine
GM-Tg-bovg-IP1833-Ab-1/ GM-Tg-bovg-IP1833-Ab-2Anti-Bovine ST7 monoclonal antibodyBovine
GM-Tg-equg-IP1833-Ab-1/ GM-Tg-equg-IP1833-Ab-2Anti-Equine ST7 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1833-Ab-1/ GM-Tg-hg-IP1833-Ab-2; GM-Tg-rg-IP1833-Ab-1/ GM-Tg-rg-IP1833-Ab-2;
GM-Tg-mg-IP1833-Ab-1/ GM-Tg-mg-IP1833-Ab-2; GM-Tg-cynog-IP1833-Ab-1/ GM-Tg-cynog-IP1833-Ab-2;
GM-Tg-felg-IP1833-Ab-1/ GM-Tg-felg-IP1833-Ab-2; GM-Tg-cang-IP1833-Ab-1/ GM-Tg-cang-IP1833-Ab-2;
GM-Tg-bovg-IP1833-Ab-1/ GM-Tg-bovg-IP1833-Ab-2; GM-Tg-equg-IP1833-Ab-1/ GM-Tg-equg-IP1833-Ab-2
Products NameAnti-ST7 monoclonal antibody
Formatmab
Target NameST7
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ST7 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1833-Ag-1Recombinant multi-species ST7/ ETS7q/ FAM4A protein


    Target information

    Target IDGM-IP1833
    Target NameST7
    Gene ID7982,64213,296911,704776,475295,493671,280933,100056055
    Gene Symbol and Synonyms9430001H04Rik,ETS7q,FAM4A,FAM4A1,Fam4a2,HELG,RAY1,SEN4,ST7,TSG7
    Uniprot AccessionQ9NRC1,Q2IBD0,A0M8T1,A4D7R9,Q2QLA6
    Uniprot Entry NameST7_HUMAN,ST7_RAT,ST7_FELCA,ST7_BOVIN,ST7_HORSE
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000004866
    Target ClassificationN/A

    The target: ST7, gene name: ST7, also named as ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7. The gene for this product maps to a region on chromosome 7 identified as an autism-susceptibility locus. Mutation screening of the entire coding region in autistic individuals failed to identify phenotype-specific variants, suggesting that coding mutations for this gene are unlikely to be involved in the etiology of autism. The function of this gene product has not been determined. Transcript variants encoding different isoforms of this protein have been described. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.